Arthritis

Anti-C5 mAb May Offer Protection

Published in TB and Outbreaks Week, October 16th, 1995

Anti-C5 monoclonal antibody therapy may prevent collagen-induced arthritis, according to a report from the Yale University School of Medicine.

It has long been believed that intraarticular complement activation plays a central role in the pathogenesis of rheumatoid arthritis. Activated B cells and plasma cells are present in inflamed synovium and in established disease.

Elevated levels of activated complement components, such as C3a, C5a and C5b-9 (membrane attack complex), have been found within inflamed rheumatoid joints, and positive correlations have been established between the degree of complement activation and the severity of joint...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (1995-10-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry